AstraZeneca PLC (NASDAQ:AZN)
| 74.06 Delayed Data As of Jun 09 |  -0.19 / -0.26%Today’s Change | 52.65 Today|||52-Week Range 76.56 | +9.23% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 74.25 |
| Today’s open | 73.95 |
| Day’s range | 73.56 - 74.29 |
| Volume | 349,930 |
| Average volume (3 months) | 4,376,678 |
| Market cap | $225.0B |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +2,588.61% |
| Earnings growth (this year) | +11.18% |
| Earnings growth (next 5 years) | +13.70% |
| Revenue growth (last year) | +17.23% |
| P/E ratio | 49.0 |
| Price/Sales | 4.77 |
| Price/Book | 6.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.12 | -0.31% |
| ABBVAbbVie | +0.50 | +0.36% |
| NVSNovartis | +0.28 | +0.28% |
| NVONovo Nordisk | -1.38 | -0.87% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | July 27, 2023 |
| EPS forecast (this quarter) | $1.01 |
| Annual revenue (last year) | $44.4B |
| Annual profit (last year) | $3.3B |
| Net profit margin | 7.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
